MPN | Tumor

How Higher Doses of Imetelstat May Benefit Patients with Relapsed/Refractory Myelofibrosis

December 6th 2020, 6:23pm

In an interview with CURE®, lead study investigator Dr. John Mascarenhas discusses what the results of the phase 2 IMbark study could mean for the future of patients with myelofibrosis.

High-Dose Imetelstat Could Offer Patients with High-Risk Myelofibrosis Improved Overall Survival

December 5th 2020, 8:00pm

An analysis of the phase 2 study IMbark shows how imetelstat can offer patients with high-risk myelofibrosis multiple clinical benefits, setting the stage for an expanded phase 3 trial.

CURE®’s 8th Annual MPN Heroes Program Honors ‘Team of Warriors’ Who Have Overcome Challenges in Myeloproliferative Neoplasms

December 5th 2020, 3:00pm

Five patient advocates, two oncologists and one caregiver were honored during CURE®’s eighth annual MPN Heroes Program.

MPN Heroes® Recognition Program 2020

December 5th 2020, 12:00am

Watch the entire MPN Heroes program here!

Jakafi and Dacogen May Improve Overall Survival in Patients with MPN

November 19th 2020, 10:00pm

Patients with myeloproliferative neoplasm (MPN) may benefit from this combination treatment if they are in the accelerated or blast phase of the disease.

Speaking Out About MPNs

August 13th 2020, 3:00pm

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Ruben Mesa about understanding a myeloproliferative neoplasm diagnosis.

Recognizing a Rare Cancer: Myeloproliferative Neoplasms

June 30th 2020, 12:03am

Survey Highlights the Unique Challenges Faced by Patients with MPNs

June 13th 2020, 1:00am

Individuals living with myeloproliferative neoplasm (MPN) often face a markedly different experience compared to those patients with other types of blood cancer. Unfortunately, there tends to be less known about this population due to its smaller size. But tools like the recently published “Blood Cancer in America” 2020 survey aim to help highlight the disparities faced by the MPN community and give a voice to those who may feel unheard.

Attending Education Events is Beneficial to Patients and Clinicians

April 16th 2020, 7:29pm

MPN Hero Dr. Irum Khan discusses how education events for patients with cancer are helpful to both the patient and the clinician.

Patient-Doctor Duo: The Basics of Myeloproliferative Neoplasms

April 14th 2020, 2:05am

In this special edition of the “CURE Talks Cancer” podcast, we teamed up with our sister publication “OncLive on Air” to speak with a patient-doctor duo on myeloproliferative neoplasms.